Lotus Pharma Cash Flow - Annual (OTCMKTS:LTUS)

Add to My Stocks
$0.01 $0 (0%) LTUS stock closing price Oct 12, 2018 (Closing)

The financial analysis of LTUS requires an investor to check the cash flows for Lotus Pharma. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Lotus Pharma profits one has to check the income statement and for Lotus Pharma debt one has to check the balance sheet. Lotus Pharma cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. Lotus Pharma had cash and cash equivalents of $3.94M at the beginning of the year and $1.33M at year end for 2010. Lotus Pharma had an inflow of $26.77M from operating activities, $- spend due to financing activities, and $-29.44M outflow due to investing activities for 2010.

View details of Lotus Pharma cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec20102009
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow2.45M3.6M
Net Increase (Decrease) in Assets Liabilities1.76M8.98M
Cash From (used in) Discontinued Operations--
Other Adjustments Net8.13M2.34M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-29.44M-11.11M
Acquisition Disposition of Subsidiaires--
Increase (Decrease) in Investments--
Other Cash Inflow (Outflow) from Investment Activities--17.58M
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares--
Issuance (Repayment) of Debt Securities--
Increase (Decrease) in Bank & Other Borrowings--
Payment of Dividends & Other Cash Distributions--
Other Cash from (used by) Financing Activities--
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash--
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year3.94M1.27M
Cash & Equivalents at Year End1.33M3.94M
All figures in USD. M: Millions of USD, B: Billions of USD.

Lotus Pharma stock price history provides insight into historical stock price fluctuations, and Lotus Pharma stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Lotus Pharma has cash of $1.33M on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Lotus Pharma stock price.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Lotus Pharma gained $26.77M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash from investing stood at a negative value of $-29.44M for LTUS stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $- for Lotus Pharma.

Key Financial Ratios For Lotus Pharma Cash Flow

Annual Cash Flow Statements For Lotus Pharmaceuticals Inc Peers

China Sky One Medical cash flow, Guangzhou Pharma cash flow, Imagenetix cash flow, Vertical Health cash flow